Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Mar 1;97(5):1155–1164. doi: 10.1172/JCI118529

A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

H J Willison 1, G M O'Hanlon 1, G Paterson 1, J Veitch 1, G Wilson 1, M Roberts 1, T Tang 1, A Vincent 1
PMCID: PMC507167  PMID: 8636426

Abstract

IgM paraproteins associated with autoimmune peripheral neuropathy and anti-Pr cold agglutinins react with sialic acid epitopes present on disialylated gangliosides including GD1b, GT1b, GQ1b, and GD3. A causal relationship between the paraprotein and the neuropathy has never been proven experimentally. From peripheral blood B cells of an affected patient, we have cloned a human hybridoma secreting an antidisialosyl IgM mAb, termed Ha1, that shows identical structural and functional characteristics to its serum counterpart. Variable region analysis shows Ha1 is encoded by the same VH1 family heavy chain gene, V1-18, as the only other known anti-Pr antibody sequence and is somatically mutated, suggesting that it [correction of is] arose in vivo in response to antigenic stimulation. In the rodent peripheral nervous system, Ha1 immunolocalizes to dorsal root ganglia, motor nerve terminals, muscle spindles, myelinated axons, and nodes of Ranvier. After intraperitoneal injection of affinity-purified antibody into mice for 10 d, electrophysiological recordings from the phrenic nerve-hemidiaphragm preparation demonstrated impairment of nerve excitability and a reduction in quantal release of neurotransmitter. These data unequivocally establish that an antidisialosyl antibody can exert pathophysiological effects on the peripheral nervous system and strongly support the view that the antibody contributes to the associated human disease.

Full Text

The Full Text of this article is available as a PDF (418.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arai M., Yoshino H., Kusano Y., Yazaki Y., Ohnishi Y., Miyatake T. Ataxic polyneuropathy and anti-Pr2 IgM kappa M proteinemia. J Neurol. 1992 Mar;239(3):147–151. doi: 10.1007/BF00833915. [DOI] [PubMed] [Google Scholar]
  2. Arasaki K., Kusunoki S., Kudo N., Kanazawa I. Acute conduction block in vitro following exposure to antiganglioside sera. Muscle Nerve. 1993 Jun;16(6):587–593. doi: 10.1002/mus.880160603. [DOI] [PubMed] [Google Scholar]
  3. Brindel I., Preud'homme J. L., Vallat J. M., Vincent D., Vasquez J. L., Jauberteau M. O. Monoclonal IgM reactive with several gangliosides in a chronic relapsing polyneuropathy. Neurosci Lett. 1994 Nov 7;181(1-2):103–106. doi: 10.1016/0304-3940(94)90570-3. [DOI] [PubMed] [Google Scholar]
  4. Campbell M. J., Zelenetz A. D., Levy S., Levy R. Use of family specific leader region primers for PCR amplification of the human heavy chain variable region gene repertoire. Mol Immunol. 1992 Feb;29(2):193–203. doi: 10.1016/0161-5890(92)90100-c. [DOI] [PubMed] [Google Scholar]
  5. Chiba A., Kusunoki S., Shimizu T., Kanazawa I. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome. Ann Neurol. 1992 Jun;31(6):677–679. doi: 10.1002/ana.410310619. [DOI] [PubMed] [Google Scholar]
  6. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  7. Daune G. C., Farrer R. G., Dalakas M. C., Quarles R. H. Sensory neuropathy associated with monoclonal immunoglobulin M to GD1b ganglioside. Ann Neurol. 1992 Jun;31(6):683–685. doi: 10.1002/ana.410310621. [DOI] [PubMed] [Google Scholar]
  8. Fishman P. H., Pacuszka T., Orlandi P. A. Gangliosides as receptors for bacterial enterotoxins. Adv Lipid Res. 1993;25:165–187. [PubMed] [Google Scholar]
  9. Friedman D. F., Cho E. A., Goldman J., Carmack C. E., Besa E. C., Hardy R. R., Silberstein L. E. The role of clonal selection in the pathogenesis of an autoreactive human B cell lymphoma. J Exp Med. 1991 Sep 1;174(3):525–537. doi: 10.1084/jem.174.3.525. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Griffin J. W. Antiglycolipid antibodies and peripheral neuropathies: links to pathogenesis. Prog Brain Res. 1994;101:313–323. doi: 10.1016/s0079-6123(08)61959-7. [DOI] [PubMed] [Google Scholar]
  11. Hartung H. P., Pollard J. D., Harvey G. K., Toyka K. V. Immunopathogenesis and treatment of the Guillain-Barré syndrome--Part II. Muscle Nerve. 1995 Feb;18(2):154–164. doi: 10.1002/mus.880180203. [DOI] [PubMed] [Google Scholar]
  12. Hays A. P., Latov N., Takatsu M., Sherman W. H. Experimental demyelination of nerve induced by serum of patients with neuropathy and an anti-MAG IgM M-protein. Neurology. 1987 Feb;37(2):242–256. doi: 10.1212/wnl.37.2.242. [DOI] [PubMed] [Google Scholar]
  13. Herron B., Willison H. J., Veitch J., Roelcke D., Illis L. S., Boulton F. E. Monoclonal IgM cold agglutinins with anti-Pr1d specificity in a patient with peripheral neuropathy. Vox Sang. 1994;67(1):58–63. doi: 10.1111/j.1423-0410.1994.tb05039.x. [DOI] [PubMed] [Google Scholar]
  14. Ilyas A. A., Quarles R. H., Dalakas M. C., Fishman P. H., Brady R. O. Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups. Ann Neurol. 1985 Dec;18(6):655–659. doi: 10.1002/ana.410180605. [DOI] [PubMed] [Google Scholar]
  15. Jacobs B. C., Endtz H., van der Meché F. G., Hazenberg M. P., Achtereekte H. A., van Doorn P. A. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome. Ann Neurol. 1995 Feb;37(2):260–264. doi: 10.1002/ana.410370218. [DOI] [PubMed] [Google Scholar]
  16. Jefferies L. C., Carchidi C. M., Silberstein L. E. Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment. J Clin Invest. 1993 Dec;92(6):2821–2833. doi: 10.1172/JCI116902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Mancini G., Carbonara A. O., Heremans J. F. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry. 1965 Sep;2(3):235–254. doi: 10.1016/0019-2791(65)90004-2. [DOI] [PubMed] [Google Scholar]
  18. Matsuda F., Shin E. K., Nagaoka H., Matsumura R., Haino M., Fukita Y., Taka-ishi S., Imai T., Riley J. H., Anand R. Structure and physical map of 64 variable segments in the 3'0.8-megabase region of the human immunoglobulin heavy-chain locus. Nat Genet. 1993 Jan;3(1):88–94. doi: 10.1038/ng0193-88. [DOI] [PubMed] [Google Scholar]
  19. Monaco S., Ferrari S., Bonetti B., Moretto G., Kirshfink M., Nardelli E., Nobile-Orazio E., Zanusso G., Rizzuto N., Tedesco F. Experimental induction of myelin changes by anti-MAG antibodies and terminal complement complex. J Neuropathol Exp Neurol. 1995 Jan;54(1):96–104. doi: 10.1097/00005072-199501000-00012. [DOI] [PubMed] [Google Scholar]
  20. Montecucco C., Schiavo G., Gao Z., Bauerlein E., Boquet P., DasGupta B. R. Interaction of botulinum and tetanus toxins with the lipid bilayer surface. Biochem J. 1988 Apr 15;251(2):379–383. doi: 10.1042/bj2510379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. O'Leary C., Willison H. J. Immunological investigation. Curr Opin Neurol. 1995 Oct;8(5):349–353. doi: 10.1097/00019052-199510000-00004. [DOI] [PubMed] [Google Scholar]
  22. Obi T., Kusunoki S., Takatsu M., Mizoguchi K., Nishimura Y. IgM M-protein in a patient with sensory-dominant neuropathy binds preferentially to polysialogangliosides. Acta Neurol Scand. 1992 Aug;86(2):215–218. doi: 10.1111/j.1600-0404.1992.tb05069.x. [DOI] [PubMed] [Google Scholar]
  23. Parry G. J. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy. Muscle Nerve. 1994 Jan;17(1):97–99. doi: 10.1002/mus.880170114. [DOI] [PubMed] [Google Scholar]
  24. Pascual V., Victor K., Lelsz D., Spellerberg M. B., Hamblin T. J., Thompson K. M., Randen I., Natvig J., Capra J. D., Stevenson F. K. Nucleotide sequence analysis of the V regions of two IgM cold agglutinins. Evidence that the VH4-21 gene segment is responsible for the major cross-reactive idiotype. J Immunol. 1991 Jun 15;146(12):4385–4391. [PubMed] [Google Scholar]
  25. Paterson G., Wilson G., Kennedy P. G., Willison H. J. Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. J Immunol. 1995 Sep 15;155(6):3049–3059. [PubMed] [Google Scholar]
  26. Roberts M., Willison H. J., Vincent A., Newsom-Davis J. Multifocal motor neuropathy human sera block distal motor nerve conduction in mice. Ann Neurol. 1995 Jul;38(1):111–118. doi: 10.1002/ana.410380118. [DOI] [PubMed] [Google Scholar]
  27. Roberts M., Willison H., Vincent A., Newsom-Davis J. Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release. Lancet. 1994 Feb 19;343(8895):454–455. doi: 10.1016/s0140-6736(94)92694-8. [DOI] [PubMed] [Google Scholar]
  28. Roelcke D., Kreft H. Characterization of various anti-Pr cold agglutinins. Transfusion. 1984 May-Jun;24(3):210–213. doi: 10.1046/j.1537-2995.1984.24384225023.x. [DOI] [PubMed] [Google Scholar]
  29. Santoro M., Uncini A., Corbo M., Staugaitis S. M., Thomas F. P., Hays A. P., Latov N. Experimental conduction block induced by serum from a patient with anti-GM1 antibodies. Ann Neurol. 1992 Apr;31(4):385–390. doi: 10.1002/ana.410310407. [DOI] [PubMed] [Google Scholar]
  30. Schwerer B., Lassmann H., Kitz K., Bernheimer H. Ganglioside GM1, a molecular target for immunological and toxic attacks: similarity of neuropathological lesions induced by ganglioside-antiserum and cholera toxin. Acta Neuropathol. 1986;72(1):55–61. doi: 10.1007/BF00687947. [DOI] [PubMed] [Google Scholar]
  31. Silberstein L. E., Jefferies L. C., Goldman J., Friedman D., Moore J. S., Nowell P. C., Roelcke D., Pruzanski W., Roudier J., Silverman G. J. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood. 1991 Nov 1;78(9):2372–2386. [PubMed] [Google Scholar]
  32. Takigawa T., Yasuda H., Kikkawa R., Shigeta Y., Saida T., Kitasato H. Antibodies against GM1 ganglioside affect K+ and Na+ currents in isolated rat myelinated nerve fibers. Ann Neurol. 1995 Apr;37(4):436–442. doi: 10.1002/ana.410370405. [DOI] [PubMed] [Google Scholar]
  33. Tatum A. H. Experimental paraprotein neuropathy, demyelination by passive transfer of human IgM anti-myelin-associated glycoprotein. Ann Neurol. 1993 May;33(5):502–506. doi: 10.1002/ana.410330514. [DOI] [PubMed] [Google Scholar]
  34. Tettamanti G., Riboni L. Gangliosides and modulation of the function of neural cells. Adv Lipid Res. 1993;25:235–267. [PubMed] [Google Scholar]
  35. Thomas F. P., Trojaborg W., Nagy C., Santoro M., Sadiq S. A., Latov N., Hays A. P. Experimental autoimmune neuropathy with anti-GM1 antibodies and immunoglobulin deposits at the nodes of Ranvier. Acta Neuropathol. 1991;82(5):378–383. doi: 10.1007/BF00296548. [DOI] [PubMed] [Google Scholar]
  36. Thompson K. M., Hough D. W., Maddison P. J., Melamed M. D., Hughes-Jones N. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner. J Immunol Methods. 1986 Nov 20;94(1-2):7–12. doi: 10.1016/0022-1759(86)90208-5. [DOI] [PubMed] [Google Scholar]
  37. Thompson K. M., Sutherland J., Barden G., Melamed M. D., Randen I., Natvig J. B., Pascual V., Capra J. D., Stevenson F. K. Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope. Scand J Immunol. 1991 Oct;34(4):509–518. doi: 10.1111/j.1365-3083.1991.tb01574.x. [DOI] [PubMed] [Google Scholar]
  38. Tomlinson I. M., Walter G., Marks J. D., Llewelyn M. B., Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J Mol Biol. 1992 Oct 5;227(3):776–798. doi: 10.1016/0022-2836(92)90223-7. [DOI] [PubMed] [Google Scholar]
  39. Uemura K., Roelcke D., Nagai Y., Feizi T. The reactivities of human erythrocyte autoantibodies anti-Pr2, anti-Gd, Fl and Sa with gangliosides in a chromatogram binding assay. Biochem J. 1984 May 1;219(3):865–874. doi: 10.1042/bj2190865. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Williams S. C., Winter G. Cloning and sequencing of human immunoglobulin V lambda gene segments. Eur J Immunol. 1993 Jul;23(7):1456–1461. doi: 10.1002/eji.1830230709. [DOI] [PubMed] [Google Scholar]
  41. Willison H. J. Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psychiatry. 1994 Nov;57(11):1303–1307. doi: 10.1136/jnnp.57.11.1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Willison H. J., Kennedy P. G. Gangliosides and bacterial toxins in Guillain-Barré syndrome. J Neuroimmunol. 1993 Jul;46(1-2):105–112. doi: 10.1016/0165-5728(93)90239-u. [DOI] [PubMed] [Google Scholar]
  43. Willison H. J., Paterson G., Kennedy P. G., Veitch J. Cloning of human anti-GM1 antibodies from motor neuropathy patients. Ann Neurol. 1994 Apr;35(4):471–478. doi: 10.1002/ana.410350416. [DOI] [PubMed] [Google Scholar]
  44. Willison H. J., Paterson G., Veitch J., Inglis G., Barnett S. C. Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1178–1183. doi: 10.1136/jnnp.56.11.1178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Willison H. J., Trapp B. D., Bacher J. D., Dalakas M. C., Griffin J. W., Quarles R. H. Demyelination induced by intraneural injection of human antimyelin-associated glycoprotein antibodies. Muscle Nerve. 1988 Nov;11(11):1169–1176. doi: 10.1002/mus.880111111. [DOI] [PubMed] [Google Scholar]
  46. Willison H. J., Veitch J., Paterson G., Kennedy P. G. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry. 1993 Feb;56(2):204–206. doi: 10.1136/jnnp.56.2.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Wirguin I., Suturkova-Milosevic L., Della-Latta P., Fisher T., Brown R. H., Jr, Latov N. Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides. Ann Neurol. 1994 Jun;35(6):698–703. doi: 10.1002/ana.410350610. [DOI] [PubMed] [Google Scholar]
  48. Yuki N., Miyatani N., Sato S., Hirabayashi Y., Yamazaki M., Yoshimura N., Hayashi Y., Miyatake T. Acute relapsing sensory neuropathy associated with IgM antibody against B-series gangliosides containing a GalNAc beta 1-4(Gal3-2 alpha NeuAc8-2 alpha NeuAc)beta 1 configuration. Neurology. 1992 Mar;42(3 Pt 1):686–689. doi: 10.1212/wnl.42.3.686. [DOI] [PubMed] [Google Scholar]
  49. Yuki N., Sato S., Tsuji S., Ohsawa T., Miyatake T. Frequent presence of anti-GQ1b antibody in Fisher's syndrome. Neurology. 1993 Feb;43(2):414–417. doi: 10.1212/wnl.43.2.414. [DOI] [PubMed] [Google Scholar]
  50. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993 Nov 1;178(5):1771–1775. doi: 10.1084/jem.178.5.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Yuki N., Taki T., Takahashi M., Saito K., Tai T., Miyatake T., Handa S. Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1 a epitope. Infect Immun. 1994 May;62(5):2101–2103. doi: 10.1128/iai.62.5.2101-2103.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Yuki N., Taki T., Takahashi M., Saito K., Yoshino H., Tai T., Handa S., Miyatake T. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome. Ann Neurol. 1994 Nov;36(5):791–793. doi: 10.1002/ana.410360517. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES